Following a successful audit by SIRIM (Standard and Industrial Research Institute of Malaysia), ExcelVite has obtained a RSPO Supply Chain Certificate.
Photo © iStockphoto.com/nui7711
After obtaining certification from the Malaysian Sustainable Palm Oil Supply Chain Certification Standard (MSPO SCCS) in June of 2019, ExcelVite (Edison, NJ) immediately got to work identifying gaps that needed to be bridged in order to achieve RSPO Supply Chain Certification. Now, following a successful audit by SIRIM (Standard and Industrial Research Institute of Malaysia), ExcelVite has obtained the RSPO Supply Chain Certificate.
The significance of this new certification is that it has worldwide recognition while the MSPO SCCS is the nationally recognized standard that aligns with Malaysian law. “As a leading PIC/S GMP-certified palm phytonutrient producer, we are proud to achieve RSPO-SC certification that underscores our commitment in sustainability responsibilities while providing high quality products to our customers worldwide,” said YT Chan, senior QA manager and head of sustainability committee at ExcelVite, in a press release. “With strong commitment from the management, we hope to do more for the local environment, with positive social and economic impact to local smallholders in Malaysia.”
“Our Sustainability Initiative put in place a few years ago has beared fruits. We will continue to promote the awareness of certified-sustainable palm oil to our existing and potential customers with the aim to support them as they, with the peace of mind, continue to use ExcelVite’s branded flagship products - EVNol and EVNol SupraBio (patented & bioenhanced full spectrum palm tocotrienol complex) as well as EVTene (natural palm mixed carotene complex),” said WH Leong, CEO, ExcelVite, in a press release.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.